Sample Submission Form: BMH-Clinical Proteomics Unit
Welcome to the Clinical Proteomics Unit at BMH. This guide provides essential information regarding our sample submission process. To ensure the integrity of your samples and the accuracy of our downstream proteomic analysis, all investigators are required to complete the official Sample Submission Form prior to or upon the arrival of samples at our facility.
Overview of the Submission Process
The submission form serves as a critical document that links your physical samples to our laboratory information management system. It captures vital metadata, sample conditions, and research objectives. Without a properly completed form, laboratory staff may delay processing to prevent experimental errors or safety hazards.
Required Information for Submission
When preparing your submission, please ensure the following details are prepared:
- Principal Investigator (PI) Information: Contact details, department, and relevant grant/budget codes for billing.
- Sample Inventory: A complete list of sample identifiers, including concentration, buffer composition, and total volume.
- Preparation Methods: A description of how the samples were harvested, lysed, and quantified (e.g., BCA assay, Bradford assay).
- Analysis Goals: Whether the study is a discovery-based proteomics project, targeted quantification (SRM/PRM), or a post-translational modification analysis.
- Safety Data: Clear disclosure of any infectious, radioactive, or hazardous materials present in the samples.
Guidelines for Sample Preparation
The quality of your data is directly correlated to the quality of the material submitted. For optimal results:
- Purity: Ensure samples are free from high concentrations of non-volatile salts, detergents (like SDS, unless specifically requested), and polymers.
- Quantification: Always use a validated protein quantification method. Estimations based on visual inspection or simple absorbance are often inaccurate.
- Storage: Samples should be kept at -80C and transported on dry ice to maintain protein stability.
Data Security and Privacy
At the BMH-Clinical Proteomics Unit, we adhere to strict data governance standards. The information provided in your submission form is used exclusively for project management and internal reporting. Sensitive clinical data related to human subjects must be de-identified prior to submission in compliance with institutional ethics boards.
Submission Workflow
- Download the Form: Obtain the latest version of the form from our secure institutional portal.
- Completion: Fill out all mandatory fields. Digital signatures are preferred.
- Email Submission: Send a copy of the completed form to the Lab Manager.
- Sample Handover: Attach a printed copy of the form to your shipment or hand it directly to the designated drop-off personnel.
Contact Information
If you encounter technical difficulties while completing the form or if you require a consultation regarding experimental design, please contact our administrative team via the main BMH facility dashboard. Early consultation often prevents costly errors and optimizes the analytical pipeline for your specific research needs.
